Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma

M. Schlumberger, R. Elisei, S. Müller, P. Schöffski, M. Brose, M. Shah, L. Licitra, J. Krajewska, M. C. Kreissl, B. Niederle, E. E.W. Cohen, L. Wirth, H. Ali, D. O. Clary, Y. Yaron, M. Mangeshkar, D. Ball, B. Nelkin, S. Sherman

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences